Not long ago, the FDA (Food and Drug Administration) approved a drug to fight/treat COVID-19. It is called REMDESIVIR, and it appears to lessen the recovery time period by at least five days! Numerous trials had shown a reduction in healing time from fifteen to ten days and a reduction in the need for “oxygen” treatments.
Prior to this complete approval, the drug had been used as an “emergency” remedy, and it has been being used more and more widely as time has passed— even as part of the therapy for President Trump a few weeks ago.
In short supply for quite some time after it first was released to doctors, the product of Gilead Sciences, Inc., is becoming much more widely available to hospitals across the United States and is sold under the brand name of “VEKLURY.”
To initially qualify for using this drug, patients should be at least twelve years old and have a body weight of at least eightyeight pounds and be hospitalized for “corona-virus infection.” They should also undergo liver and kidney tests to make sure it is safe for their particular physical condition(s).
To make a long story shorter, this drug works by stopping, or at least slowing down, a substance that the offending virus uses to multiply by making many duplicates of itself. If a virus cannot replicate, it cannot survive!
The typical or recommended price of treatment is not cheap, from about $2400 to $3200, depending upon location/insurance/ income/deductibles, etc.
I must report, though, that this treatment is not recommended for use with “hydroxychloroquine” and that some studies apparently have found differing results (successes and failures) of this treatment.
I am just reporting what I have read and heard and am not a doctor.
- Log in or Subscribe to post comments.